30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Vipin Garg

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
President, Chief Executive Officer, Director Neos Therapeutics Inc Oct. 1, 2013 - June 27, 2018
President, Chief Executive Officer, Director Ocera Therapeutics Inc Oct. 1, 2000 - July 15, 2013
Vipin Garg's trades of Altimmune Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-09-01 2022-08-31
PlS Planned sale
5,245 -16.6%
333.60
US$2,868,396 		5,245 -16.6% 333.60 US$2,868,396
2022-08-12 2022-08-12
PlS Planned sale
21,900 +4.5%
34.36
US$2,150,104 		21,900 +4.5% 34.36 US$2,150,104
2019-09-05 2019-09-05
B Purchase
33,637 +36.3%
396.83
US$1,024,448 		33,637 +36.3% 396.83 US$1,024,448